How should HIV vaccine efficacy trials be conducted? diverse U.S. communities speak out.  

Oleh:

Kegeles, Susan M. ; Johnson, Mallory O. ; Strauss, Ronald P. ; Ralston, Brady ; Hays, Robert B. ; Metzger, David S. ; McLellan-Lemal, Eleanor ; MacQueen, Kathleen M.

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Aids Education and Prevention: An Interdisciplinary Journal vol. 18 no. 06 (Dec. 2006), page 560.
Topik: HIV/AIDS ; HIV Vaccine ;

Ketersediaan

Perpustakaan PKPM Nomor Panggil: A94 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Developing an effective vaccine remains a critical long-term approach to HIV prevention. Every efficacy trial ahould be responsive to the concern of participating communities because the successful development of an HIV preventive veccine will require long-term involvement of people who have been marginalized and who distrust the goverment and biomedical research.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali